| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/06/2011 | US20110003833 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/06/2011 | US20110003831 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003821 Pyrrolotriazine kinase inhibitors |
| 01/06/2011 | US20110003820 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/06/2011 | US20110003818 Substituted 2-Carboxamide Cycloamino Ureas |
| 01/06/2011 | US20110003812 Human Adam-10 Inhibitors |
| 01/06/2011 | US20110003809 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors |
| 01/06/2011 | US20110003807 Thiazole derivatives |
| 01/06/2011 | US20110003806 Heteroaryls and uses thereof |
| 01/06/2011 | US20110003805 Concomitant drug |
| 01/06/2011 | US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003792 Anti-inflammatory agents |
| 01/06/2011 | US20110003791 Cyclized Derivatives as EG-5 Inhibitors |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003788 Fused heterocyclic derivative and use thereof |
| 01/06/2011 | US20110003786 2-Carboxamide Cycloamino Ureas |
| 01/06/2011 | US20110003785 Fused Thiazole Derivatives As Kinase Inhibitors |
| 01/06/2011 | US20110003778 Mineralcorticoid receptor antagonists for the treatment of endometriosis |
| 01/06/2011 | US20110003777 Methods of Treatment Employing Prolonged Continuous Infusion of Belinostat |
| 01/06/2011 | US20110003768 Prebiotic compositions |
| 01/06/2011 | US20110003754 Peptide-Conjugated Oligonucleotide Therapeutic and Method of Making and Using Same |
| 01/06/2011 | US20110003753 COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER |
| 01/06/2011 | US20110003751 Novel Immunoregulatory Peptides, Compositions and Uses Thereof |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003742 Naphthalimide Dosing by N-Acetyl Transferase Genotyping |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110003318 Nucleotide and protein sequence of mammastatin and methods of use |
| 01/06/2011 | US20110003008 Mesenchymal stem cell particles |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002992 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002979 Styrene maleic anhydride based formulation for male contraception and prostate cancer |
| 01/06/2011 | US20110002978 Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
| 01/06/2011 | US20110002977 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002969 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 01/06/2011 | US20110002964 Methods for cancer treatment using stem cells |
| 01/06/2011 | US20110002963 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/06/2011 | US20110002961 Interleukin 12 paracrine gene delivery enhanced CTL immunotherapy |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002947 Leptomycin derivatives |
| 01/06/2011 | US20110002936 Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof |
| 01/06/2011 | US20110002934 Uses of anti-cd40 antibodies |
| 01/06/2011 | US20110002933 Dr4 antibodies and uses thereof |
| 01/06/2011 | US20110002930 Activated T Cells |
| 01/06/2011 | US20110002924 Tweak receptor agonists as anti-angiogenic agents |
| 01/06/2011 | US20110002923 Methods of inhibiting tumor growth using ttk antagonists |
| 01/06/2011 | US20110002922 Cell growth inhibitors containing anti-glypican 3 antibody |
| 01/06/2011 | US20110002921 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002920 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002919 Antagonists of neuropilin receptor function and use thereof |
| 01/06/2011 | US20110002917 Antibody constant domain regions and uses thereof |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002903 Immunogenic control of tumours and tumour cells |
| 01/06/2011 | US20110002898 Vaccine compositions |
| 01/06/2011 | US20110002896 Methods and related compositions for reduction of fat |
| 01/06/2011 | US20110002890 Treatment of tumors with genetically engineered herpes virus |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
| 01/06/2011 | US20110002886 Tetrahydrofuro [3,4-d] dioxolane compounds for use in the treatment of viral infections and cancer |
| 01/06/2011 | US20110002885 Methods of using isolated recombinant polypeptide antagonists of sdf-1 |
| 01/06/2011 | US20110002882 Methods of treating cancer using il-21 |
| 01/06/2011 | US20110002881 Treatment and prophylaxis |
| 01/06/2011 | US20110002879 Combinations of Pyrazole Kinase Inhibitors |
| 01/06/2011 | US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties |
| 01/06/2011 | US20110002852 Stem cells for use in locating and targeting tumor cells |
| 01/06/2011 | US20110002850 Nitro-Imidazole Hypoxia Imaging Agent |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | US20110002846 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neural and glial tumors of the brain |
| 01/06/2011 | US20110002845 Methods of treating, diagnosing or detecting fgf21-associated disorders |
| 01/06/2011 | US20110002844 Stabilization of macromolecular membranes |
| 01/06/2011 | US20110000480 Administration of interferon for prophylaxis against or treatment of pathogenic infection |
| 01/06/2011 | CA2804190A1 Phosphorus containing quinazoline compounds and methods of use |
| 01/06/2011 | CA2767130A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | CA2767127A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 01/06/2011 | CA2767097A1 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/06/2011 | CA2767096A1 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | CA2767064A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | CA2767012A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 01/06/2011 | CA2766967A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | CA2766909A1 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | CA2766882A1 Therapeutic compounds and compositions |
| 01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
| 01/06/2011 | CA2766855A1 Substituted 2-carboxamide cycloamino ureas |
| 01/06/2011 | CA2766853A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors |
| 01/06/2011 | CA2766770A1 Novel antibodies and their uses in therapeutic and diagnostic methods |
| 01/06/2011 | CA2766762A1 Novel conjugates, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | CA2766162A1 Smac mimetic |
| 01/06/2011 | CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | CA2764185A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/05/2011 | EP2270503A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270502A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270501A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270500A1 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270499A1 Method for diagnosing non-small cell lung cancers |